MetLife Investment Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $780K | Sell |
|
|||||
|
2025
Q1 | $685K | Buy |
|
|||||
|
2024
Q4 | $792K | Buy |
|
|||||
|
2024
Q3 | $785K | Hold |
|
|||||
|
2024
Q2 | $618K | Buy |
|
|||||
|
2024
Q1 | $540K | Buy |
|
|||||
|
2023
Q4 | $181K | Hold |
|
|||||
|
2023
Q3 | $128K | Hold |
|
|||||
|
2023
Q2 | $210K | Hold |
|
|||||
|
2023
Q1 | $214K | Buy |
|
|||||
|
2022
Q4 | $75.5K | Sell |
|
|||||
|
2022
Q3 | $170K | Hold |
|
|||||
|
2022
Q2 | $164K | Buy |
|
|||||
|
2022
Q1 | $113K | Sell |
|
|||||
|
2021
Q4 | $198K | Buy |
|
|||||
|
2021
Q3 | $202K | Sell |
|
|||||
|
2021
Q2 | $399K | Hold |
|
|||||
|
2021
Q1 | $462K | Sell |
|
|||||
|
2020
Q4 | $585K | Buy |
|
|||||
|
2020
Q3 | $208K | Buy |
|
|||||
|
2020
Q2 | $175K | Hold |
|
|||||
|
2020
Q1 | $104K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $117K | Buy |
|